Clinical Trial Results: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia [Phase 1, Phase 2]

View source ↗

Summary

Open-label pharmacokinetic, pharmacodynamic, and drug-drug interaction study of dotinurad with allopurinol in gout patients with hyperuricemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• Allopurinol (Allopurinol)
• Dotinurad (dotinurad)

Snippet

Sponsor: Urica Therapeutics Inc. | Conditions: Gout, Hyperuricemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-06-10